Both improved routine care o f the newborn and management o f newborn illness have dramatically reduced the infant mortality rate in the United States in the last 20 yr (101). The single most important variable in infant survival is birth weight. Efforts to reduce mortality among low birth weight infants, most o f them premature, have been extremely successful, and the USA now has one o f the lowest birth weight specific neonatal mortality rates in the world
. For ( 5 1 , 73, 123) .
NEONATAL INTENSIVE CARE

Hospital-based nurseries for premature babies were first developed in the United States in the 1920s, but it was not until the late 1940s that research on their tiny occupants was initiated. Despite some therapeutic advances such as the use o f antibiotics in the treatment o f septic infants, there was little, i f any, improvement in neonatal mortality rates between the mid-1940s and the early 1960s. Indeed, therapeutic advances were often overshadowed by therapeutic misadventures (73). For example, the use o f high oxygen levels for the treatment o f small babies with apnea led to the subsequent development o f retrolental fibroplas~a.
When oxygen was recognized as a cause o f retrolental fibroplasia, curtailment o f oxygen therapy led to an increased incidence o f neurologic sequelae. Although many antibiotics were effective, the prophylactic use o f the sulfonamides led to an increased incidence o f kernicterus; therapeutic doses o f chloramphenicol in prematures led to cardiovascular collapse and shock, the "gray baby syndrome." Vitamin K prevented hemorrhagic disease o f the newborn, but its overzealous use led to hyperbilirubinemia and kernicterus.
These results and early observations ( 5 1, 123) (45, 46, 17 1) . The development o f apnea monitors (42) Similarly, because the care o f the infants and clinical research are so closely combined, countless medical students and house officers received their first, and often their only exposure to clinical research during their rotation on the nursery services. Many students have had their curiosity heightened and been stimulated to enter a career in investigative medicine. This factor is a frequently overlooked, but crucial contribution of the clinical research centers.
that as many as 60% o f low birth weight infants had neurologic or intellectual impairment led many physicians to question any attempt to improve the survival o f low birth weight infants. In the early and mid-1960s, an abrupt improvement in perinatal mortality occurred, which has further accelerated in the 1970s and 1980s. This improved infant survival can, in large part, be attributed to the development o f intensive care nurseries, including clinical research centers. In these centers, careful and meticulous clinical investigation on critically ill infants has markedly improved neurologic, intellectual, and developmental outcome. Much o f this improvement is a result o f improved fktal monitoring and care. For example, study o f temperature coni.ro1 and the metabolic effects o f temperature alterations led to the development and improvement o f infant warmers
NUTRITION
Total parentcral nutrition. Many prematurely born infants
have incomplete development of their gastrointestinal systems and cannot tolerate oral feedings. Investigators at the University of Pennsylvania first investigated the feasibility of supplying all nutrients on a long-term basis by the intravenous route, a procedure now termed total parenteral nutrition (55) . These studies, initially carried out in Beagle puppies, were soon applied to humans. One of the first pediatric applications of total parenteral nutrition was in an infant with a markedly shortened intestine who was studied in a clinical research center (237) . The use of total parenteral nutrition in neonates with surgical disorders soon led to its use in infants of very low birth weight. This was aided by the development of catheters constructed of relatively inert materials which caused minimal vascular dysfunction and were adaptable for infant use (23) . CRC investigators soon recognized a number of biochemical and metabolic problems associated with total parenteral nutrition. These included hyperosmolarity, acidosis, hyperammonemia, azotemia and impaired glucose utilization. Subsequently, alterations in the type and content of solutions were developed to circumvent these complications (I, 54, 57,9 1). The combined use of enteral and parenteral nutrition allowed many small infants to gain weight, resist infection, and adapt to their extrauterine environment. The nutritional requirements of these low birth weight infants have also been investigated (6) . It was demonstrated that these infants' ability to handle nutrients was vastly different than in older infants; moreover, their endocrine responses were considerably different (2 17, 235) .
Use rfhzitnun milk. Another major advance in the nutrition of low birth weight infants was the use of human milk in intensive care nurseries. Previous studies suggested that human milk did not contain adequate amounts of protein to insure optimal growth of immature infants as compared with proprietary formulae that contained 3-4% protein. Drs. Gaull, Raiha and their CRC co-workers clearly demonstrated that preterm infants could grow and develop normally when fed human milk (66, 179, 180, 18 1). They also showed that breast milk contains certain amino acids essential for preterm infants (67, 182, 183). These investigators, working with infants and children with defects of sulfated amino acid metabolism, noted that preterm infants have decreased activity of hepatic cystathionase (222), and that breast milk has greater concentrations of cystine than proprietary formulae. They speculated that human milk has distinct advantages for low birth weight infants. Human milk was also found to have a number of host resistance factors that potentially could protect the preterm infants from various intestinal disorders such as necrotizing entercolitis (70). The concern was that these factors would be inactivated if the breast milk was processed, but investigators at the Stanford CRC demonstrated that pasteurization, lyophylization and freezing had little, if any, effect on the concentration and activity of these factors, including secretory IgA immunoglobulin (1 19).
Gastroc.sophageu1 r<flzi,x. Gastroesophageal reflux may lead to a variety of problems in newborns and young infants including feeding difficulties, failure to thrive, and respiratory problems. Studies in the Stanford CRC increased the awareness of US physicians in the USA of this problem (63, 64) and contributed importantly to the understanding of its pathogenesis, diagnosis, and treatment (22, 75, 76, 90) . Techniques to monitor esophageal pH for a 24-h period have elucidated the relationship between gastroesophageal reflux and pulmonary abnormalities (47, 170) .
Infants qJ du'iabetic mothers. Another Magnesium deficiency also was noted to affect calcium regulation through diminished production of parathyroid hormone (49) . Newborns with magnesium deficiency given magnesium were shown to respond appropriately with increased production of parathyroid hormone.
PRENATAL A N D OBSTETRIC MANAGEMENT
Introduction. Use of amniocentesis as a management tool for
Rh isoimmunization in the early 1960s led to the concept that the fetus is a patient, albeit an inaccessible one, and that birth is not so much a beginning as a transition from intra-to extrauterine existence. If the fetus is viewed as a patient, then increased diagnostic information has to be obtained. This led to improved areas of fetal monitoring, better description of normal fetal growth and development, better assessment of pregnancy duration and fetal nutrition, and improved diagnosis of abnormal fetal conditions including exposures to substances used by or administered to the mother.
CRC investigators have made major contributions to advances in prenatal assessment over the past 20 yr. In this section, several long term efforts that have led to improved materno-fetal care are discussed.
Fetal monitoring during labor. CRC investigators have contributed to the development and assessment of electronic and biochemical monitoring of the fetus during labor. CRC investigators were among the first to document the relationship of abnormal fetal heart rate patterns to fetal and maternal acid/ base balance (96). CRC investigators at Cleveland related abnormal fetal heart rate patterns during labor to both lowered fetal scalp blood pH (acidosis) and neonatal nervous system depression, delineated the fetal heart rate changes associated with umbilical cord entanglement and prolapse, and developed a practical classification of fetal heart rate abnormalities (1 5 1, 1.52). They also pioneered the development of "wireless" fetal monitoring (telemetry) (1 37, 138, 139, 196) . CRC research has focused on complications of fetal monitoring and limitations of fetal heart rate as an indicator of fetal stress (2 12) . The application of computer technology has permitted improved bedside clinical risk assessment (32, 190) . These computer programs can be used for I ) medical/obstetric risk identification and prediction of perinatal outcome (209), 2) perinatal data management and clinical report generation (3 l), 3) diagnosis and management of normal and abnormal labor (205, 206, 2 lo), 4) evaluation of uterine contractions (27, 28) , and 5) detection of abnormal fetal heart rate deceleration patterns (29) .
There has been considerable public and professional concern about the high cesarean birth rate associated with changes in obstetric management. A 3-fold increase in the use of abdominal delivery and changes in indicators for cesarean section over the past decade were documented (1 9). A CRC study was the first to support a National Institutes of Health Task Force conclusion that a high cesarean birth rate is not necessitated by abnormal labor progress. Using a CRC computerized database, it was found that at the CRC institution only one in four labors complicated by severe abnormality were delivered by cesarean section, compared with two of three nationally (208); moreover, this was achieved without a high operative forceps rate and with excellent infant outcome (20) .
Prenatal development of the brain. The potential contribution of prenatal events to abnormal neurobehavioral development, e.g., cerebral palsy and mental retardation, has been recognized since the nineteenth century. Until 20 yr ago, retrospective review of the histories of damaged children and adults often disclosed complicated perinatal courses, particularly birth trauma, i.e., difficult labor and delivery. Fetal brain wave (EEG) recordings made during labor as an indicator of brain damage were undertaken by CRC investigators (33) . The recording before birth wave patterns comparable to those of the neonate indicated that the brain does not "turn on," so to speak, at birth (33) . Instead, these studies indicate that central nervous system function develops throughout the prenatal period and can be disrupted before labor, resulting in aberrant long-term neurodevelopment (34, 35) . In one study (207), a specific pattern of abnormal brain wave activity (hypsarrhythmia), known to be associated with severe abnormality in the young child, was detected early in labor, clearly documenting brain damage in the antepartum period. These observations point to the need for further evaluation of central nervous system development in relation to brain damage.
CRC supported studies by Timor-Tritsch et 01. (228) , evaluated fetal movements with strain gauges on the maternal abdomen as a prelabor indicator of brain development. Several types of fetal movement were described, classified, and correlated with fetal heart rate changes (227), and fetal breathing movements (229). During extended periods of study, the fetus was noted to have alternating active and quiet periods of behavior (226). These movements were classified into several recognizable patterns, reflecting various levels of brain activity as they develop before birth.
Obstetric unalgesiu. Despite the widespread use of obstetric anesthesia, little is known about the metabolism of analgesic drugs by the mother, fetus, and neonate. CRC investigators at Cleveland have measured trace levels of drugs and their metabolites with gas chromatography/mass spectrometry in order to investigate how these agents affect the infant. Studies on meperidine, lidocaine, and 2-chloroprocaine, three drugs most commonly used for pain relief during delivery, are underway.
Meperidine. This drug causes respiratory depression in the newborn, even if given to the mother in low doses, particularly if given several hours before instead of close to delivery. It was hypothesized that the respiratory depressent effect was due to the formation of a toxic metabolite, normeperidine. Using sensitive analytic techniques, CRC investigators demonstrated the metabolic conversion of meperidine to normeperidine, and the presence of meperidine and normeperidine in blood and urine of mothers and urine of neonates (107, 108). The placental passage of normeperidine and the increased amounts of normeperidine in cord blood with time (105) explained its adverse effects on the neonate when the drug was given 3 h before delivery compared with its effect when given within 1 h of delivery.
Lidocuine. The lidocaine metabolites monoethylglycinexylidide and glycinexylidide act similarly to the parent compound. Although it was known that the use of lidocaine can adversely affect neonatal outcome, its metabolism in pregnancy and neonates had not been adequately studied. A CRC study (104) showed that lidocaine levels in maternal plasma are much higher than in fetal plasma at delivery, but that the monoethylglycine~c-ylidide and glycinexylidide levels in maternal and fetal plasma are similar, and occasionally higher in fetal than in maternal plasma, indicating their metabolic origin is to some degree from the fetus (104).
Chloroprocaine. The metabolism of chloroprocaine by plasma enzymes in the mother is so rapid that it had not been assayed previously in maternal plasma nor thought to cross the placenta. CRC investigators utilized sensitive techniques to demonstrate that placental transfer of chloroprocaine does occur (106). Lo.w levels of blood enzymes present in women with term pregnancies are adequate to metabolize most, but not all of the chloroprocaine diffusing into the blood; thus, some of the drug crosses the placenta. Chloroprocaine administration can lower maternal levels of pseudocholinesterase and have a potential adverse effect if the muscle relaxant succinylcholine is subsequently administered.
Fetal e,uposures: alcohol abuse in pregnuncy. The first report that maternal alcohol abuse was associated with fetal damage appeared in 1973. Shortly thereafter, a study of the fetal consequences of maternal alcohol abuse was begun in a CRC, cospo11-sored by the National Institute on Alcohol Abuse and Alcoholism. The first large American prospective study was performed using the computerized perinatal files of the Cleveland Perinatal CRC (204). This study of over 12,000 consecutive deliveries first identified a 2-fold risk of spontaneous abortion among the hewiest drinking 2% of pregnant women. Increased risks for congenital anomalies, intrauterine growth retardation, and full fetal alcohol syndrome were also identified.
RESPIRATORY DISTRESS SYNDROME
Introdzlction. A major cause of death among premature infants is RDS, also termed hyaline membrane disease. The more immature the infant, the greater the risk of developing the disease and the more severe the disease. When President Kennedy's newborn infant died of RDS in 1963, there was a public outcry for studies on the cause and treatment of this disorder.
Studies had already been initiated that demonstrated that the lung of infants had decreased activity of surface tension reducing material (surfactant) compared with term infants (9) . Accordingly, RDS could best be viewed as a developmental and biochemical deficiency of surfactant (68). Several CRCs were involved in studies of surfactant concentrations in amniotic fluid of pregnant women to predict when the fetus was sufficiently mature to survive in the extrauterine environment (77, 109). Methods were then developed to treat RDS successfully, including ventilator support, continuous distending airways pressure, high frequency (300/min) ventilation, and postnatal administration of artificial surfactants (43, 44, 65 , 89, 1 1 1, 125, 203, 225):
Physiology ofRDS. The physiology of RDS has been investigated by CRC-supported programs. One of the most perplexing aspects of RDS in the 1960s was the interplay of surfactant deficiency and shunts through the patent ductus arteriosus. It was known that in immature hypoxic newborns with RDS the ductus arteriosus remained patent for an abnormal length of time. Three schools of thought existed I ) that left-to-right shunts flooded the lungs and contributed to RDS symptomatology, 2) that right-to-left flow occurring through the ductus contributed to the hypoxemia of RDS, and 3) that surfactant deficiency in RDS was the main problem and that no flow occurred through the patent ductus. A CRC-supported study at Stanford (38) helped to identify subgroups of infants that exemplified all three situations depending on gestational and postnatal age. More mature infants with RDS, often with hypoxia, frequently manifest persistent fetal circulation (failure of ductal closure) with a right-to-left ductus shunt; such infants may improve with pulmonary vascular vasodilator therapy.
Biochemistry of RDS. Basic studies of the ontogeny of fetal hormones and the maturation of respiratory control centers has led to new approaches in the prevention of RDS and sudden infant death in RDS survivors with chronic lung disease. Biochemical and physiologic studies indicate that several surface active compounds, particularly dipalmitoyl lecithin and phosphatidylglycerol, stabilize the alveoli of the lung so that normal gas exchange can occur. The absence of these phospholipids, collectively termed surfactant, is the single most significant cause of RDS. Early CRC-supported research focused on fetal lipid metabolism, specifically that of fatty acids. The most significant of these fatty acids is palmitic acid, a 16-carbon saturated moleculc. Dipalmitoyl lecithin. which contains two palmitic acids, is the most important component of surfactant. Ten years ago it was believed that the 28-35-wk gestation fetus could not form dipalmitoyl lecithin, but formed a lecithin containing a different fatty acid. myristic acid, an inferior surface active agent. CRC investigators. using radioactive isotopes in tissue culture, showed that fetuses can form palmitic acid as early as 28 wk gestation (194. 197, 242) . A crucial finding was that palmitic acid could be synthesized by the fetus from the two-carbon building block, acetate.
,~lrnniocenrc,si.s. Cluck, et ul., (69) reported in 1971 a breakthrough finding that levels of amniotic fluid surfactant reflected levels-of surfartant in the fetal lung, enabling amniotic fluid analysis to be used to predict RDS. Perinatal CRC investigators in Cleveland confirmed this work within a year of the initial paper (1 36). The accuracy of the amniotic L/S ratio in predicting RDS in the newborn was confirmed in a clinical study performed in a CRC. In a series of studies published from 1972 through 1974. these same investigators suggested that the L/S ratio has a high frequency of false negative results (135, 195) . Specifically, it was suggested that when the L/S ratio was negative, as high as 90% of patients did not develop RDS. Although this finding was initially questioned, it has since been confirmed (I 10).
Research aimed at improving the clinical usefulness of amniotic fluid phospholipid determinations has continued in CRCs. For example, Kuhnert, a/. (109) developed an improved technique for determining the L/S ratio in amniotic fluid. The clinical importance of this new technique is that it is simpler and faster to perform than the older method, making it possible to obtain immediate results for clinical management even on a n emergency basis. Also. the new technique has a lower false negative rate, leading to improved prediction accuracy. Initially studied in 229 CRC patients. the new rapid method was confirmed to be clinically useful in more than 1000 patients.
Accurate prediction of pulmonary functional maturity is now a key component of perinatal management, particularly in pregnancies complicated by chronic hypertension, preeclampsia, Rh isoimmunization. or diabetes mellitus. In the presence of these problems. early delivery can improve pregnancy outcome. Using amniotic fluid phospholipid determinations, the risk for RDS can often be diminished.
Studies of amniotic fluid phospholipids in fetal disorders continue to be supported by the CRC program. These include an improved two-dimensional technique for determining phospholipids. and the use of phosphatidylglycerol levels to identify fetuses with intrauterine growth retardation, lung immaturity. and transient tachypnea of the newborn (72).
Trcufrr7c11f o/'RDS. In the early mid-1960s. it became evident that although infants with RDS were given appropriate medical and nursing care, they would often develop respiratory failure and die. With the development of endotracheal intubation and the use of mechanical ventilation. many of these infants began to survive (43, 203, 225) . The development of many of these new ventilation techniques took place in CRCs. Initially. it was cumbersome to ventilate critically ill infants, but as newer appliances were introduced, more infants with RDS survived (44, 92, 1 1 1. 125). Although few controlled prospective studies were carried out evaluating whether or not ventilators improved survival of low birth weight infants, it rapidly became evident that if onc could identify the infant at risk and assign a scoring system to determine the biochemical and physiologic abnormalities. one could correct these by the appropriate use of mechanical ventilation (43. 92). Initially. mechanical ventilation was used primarily for the support of term or large preterm infants, but as the techniques and knowledge of utilization of ventilators improved, smaller and smaller babies were ventilated successfully.
Bronchopulmonury dy.splusiu. The use of mechanical ventilation in critically ill infants, although enhancing survival, contributed to the development of a new illness, bronchopulmonary dysplasia, first recognized at the Stanford CRC (58. 145, 146, 147) . Bronchopulmonary dysplasia develops only in infants who receive mechanical ventilation and occurs in as many as 70% of such infants. The recognition of the danger of high oxygen and ventilator support led to alterations in venti!ator management, which have subsequently reduced the incidence of bronchopulmonary dysplasia (58, 92, 203) .
Other investigators feared that even though there was a n increased rate of survival with mechanical ventilation. these infants would have moderate to severe neurologic handicaps. Careful investigations in CRCs and other institutions demonstrated clearly that most infants receiving ventilatory support were neurologically undamaged. Long-term follow-up of survivors of mechanical ventilation indicated that less than 10% of these infants had survived with significant handicaps, and another 5% had mild to moderate abnormalities (92). These results were much better than results when the infants were managed in adult intensive care units.
Develoj~mcnt of'intensive cure zmits. The realization that RDS as well as other respiratory disease could be managed successfully led to the development of intensive care nurseries throughout the U.S. The development of newer ventilators and the improved knowledge of respiratory physiology have greatly improved the management of low birth weight infants.
CARDIOVASCULAR DISORDERS
Introduction. Significant advances in the medical and surgcal treatment of cardiovascular disorders of newborn infants have occurred over the past 10-15 yr. Medical aspects include improved diagnostic techniques such as Doppler and echocardiographic assessment of congenital cardiac defects and pharmacologic treatment of heart failure, pulmonary vasoconstriction, and patent ductus arteriosus.
~Wcdical manugemcni. CRC investigators at Yale first described blood gas and acid-base disorders that included respiratory failure in infants with congestive heart failure (224). Decreased serum sodium and chloride concentrations also occurred. adversely influencing the response to digitalis and diuretics.
Engle ct ul. (8 1) at Cornell found that infants tolerate a higher serum digitoxin concentration than adults without evidence of toxicity and most likely require higher serum levels for therapeutic effects. These studies showed that assessment of serum digitoxin levels provides a guide to the adequacy of digitalization and recognition of toxicity. This group also was among the first to establish safe and effective dosage of furosemide in the treatment of edema secondary to cardiac and renal disease in infants (60) . This drug is now used widely in infant intensive care units.
Barr rt ul. (14) at Alabama assessed blood volume in critically ill newborn infants. They found a poor correlation between blood volume measured with tagged albumin and blood pressure, injecting an element of caution into the once common practice of plasma volume expansion in infants with low blood pressure.
Studies in the neonatal CRC at Stanford have explored the use of tolazoline in infants with refractory hypoxemia due to neonatal pulmonary disease or persistent pulmonary hypertension (82. 220). Many infants demonstrated improved gas exchange. presumably due to the increased pulmonary blood flow secondary to tolazoline. These investigations have stimulated additional studies on myocardial function in persistent fetal circulation and the effects of tolazoline on cardiac output and cardiovascular hemodynamics.
C~~~rdiovasc~ilur xrrgerj. Correction of many previously un- The type of hemoglobin that appears during fetal development is a function of the site of synthesis as well as the gestational age of the fetus. Alpha-, @-and 7-chain globin components of fetal red blood cells are quantified by carboxymethyl-cellulose radiochromatograms to detect decreased /%chain synthesis. Patients who are heterozygous carriers of thalassemia have a 25% chance of having a homozygous child who will manifest the severest form of the disease; therefore, these procedures provide valuable information regarding the conduct of continued pregnancy or postnatal diagnosis and treatment. Similarly, the use of fetoscopy permits the prenatal diagnosis of inherited coagulation disorders including Hemophilia A, Hemophilia B (Christmas disease), and homozygous Von Willebrands disease. Immunodeficiencies such as combined immunodeficiency, Wiskott-Aldrich syndrome. chronic granulomatous disease, and X-linked agammaglobulinemia arc also potentially diagnosable (48) .
Eryfhrocyiic enzyme studies. Studies of red blood cell metabolism of fetal and newborn infants have been facilitated through the CRC at the University of Pennsylvania and the State University of New York at Syracuse. 2.3-Diphosphoglycerate is one of the principal organic phosphates of the red cell that combines reversibly with deoxyhemoglobin, decreasing the affinity of hemoglobin for oxygen. After the discovery in 1968 of rapid increase in 2,3-diphosphoglycerate content of adult erythrocytes in response to hypoxia. Oski el a/. (156) studied infants with congenital heart disease and pulmonary insufficiency and found increased 2,3-diphosphogylycerate levels. They subsequently found that the fetal hemoglobin of red blood cells of newborn infants showed no 2,3-diphosphoglycerate response to hypoxemia. These differences in the hemoglobin dissociation curve between fetal and adult hemoglobin explain many metabolic pecularities of fetal red blood cells.
Other studies by Komazawa er ul. at Syracuse (100) have examined red cell glucose phosphate isomerase and glyceraldehydc-3-phosphate dehydrogenase activities to determine their possible role in hemolysis and transient hyperbilirubinemia in newborn infants. They found no relationship between the levels of thcse cnzymcs and neonatal jaundice. Other studies have demonstrated a lower glutathione peroxidase level in newborn red blood cells, compared with adult red blood cells, and elevated pentose phosphate pathway activity in the red cells of premature infants (154, 233) . Other CRC studies provided preliminary cvidence that determination of minor hemoglobin ratios : , ,~y )~) i show an excellent linear correlation with gcstational age ( 172) .
Vitumin E d</iciency. Oski cJt a/. (155) were the first to show that vitamin E deficiency could cause hemolytic anemia in the premature infant (I 58). Infants treated with and without vitamin E supplements were studied serially over several weeks. Vitamin E administration was found to prevent or ameliorate hemolysis and subsequent anemia. Prophylactic vitamin E now is standard treatment for all low birthweight infants.
hTc.onutul blood donor stzldies. Studies conducted at the Stanford neonatal CRC have examined the immediate and longrange effectiveness of a walking-donor blood transfusion program for a neonatal ICU (169) . Heparinization of blood led to n o coagulation problems in the neonate and there was no increased risk of transmission of HbsAg; however, the incidence of cyiomegalovirus infection of recipients was increased slightly over control infants. Such a walking-donor program can provide fresh blood in small aliquots on short notice for neonatal special care units without immediate access to a blood bank; however. some risks exist which require further study.
METABOLIC DISORDERS
12rl~rcol~ol~~~,succhurido~se.~. Studies conducted in CRCs have
helped elucidate the basic defects associated with a number of neonatal disorders leading to early or progressive brain damage. Among these are the syndromes referred to as the mucopolysaccharidoses. These disorders involve the widespread accumulation of polymers of sugar-like compounds (glycosaminoglycans) in tissues. The tissues involved include brain, skeleton, and connective tissues so that growth and mental development usually are deficient.
Elucidation of the metabolic defects in the mucopolysaccharidoses becamp possible with the observation of Fratantoni, Hall, and Neufeld at the National Institutes of Health that cultured fibroblasts incorporate radioactive [35S]sulfate almost exclusi\ely into sulfated glycosaminoglycans. Studying fibroblasts of patients with mucopolysaccharidoses, these investigators showed that the accumulation of glycosaminoglycans was due not to excessive production but to decreased degradation. During the 1970s. work proceeded apace in the laboratories of Neufeld at the National Institutes of Health and Dorfman in the Chicago CRC to characterize the degradative and molecular defects in some eight types of mucopolysaccharidoses.
Dorfman's group utilized the CRC at the University of Chicago for patient evaluation. The diagnoses were established and the tissues and urine samples were used for in viiro studies of mucopolysaccaride excretion and fibroblast glycosaminoglycan metabolism. Dorfman's group, nearly simultaneously with Neufeld, described an a-iduronidase deficiency in Hurler's Syndrome and an a-iduronosulfate sulfatase deficiency in Hunter's S,yndrome ( 1 28, 202). This group ( 126) described a deficiency ol' Nacetyl galactosamine-4-sulfate sulfatase in the Moroteaux-Lamy Syndrome, The defect in Morquio's Syndrome (and hT-acetyl hexosamine sulfate sulfatase) was described by Matalon el 01. from Dorfman's laboratory ( 1 27). In later studies, the specificity of this enzyme for N-acetyl galactosamine-6-sulfate was reported (88). These now classic studies have paved the way for studies of effective treatment of these devastating disorders.
Urcu cycle di.sordc~r.s. Much of the critical work on infants with urea cycle enzymopathies was accomplished in CRCs. These disorders lead to severe metabolic disorder and often death early in life. The first patient recognized with an abnormality of urea biosynthesis was reported by Allan and co-workers in 1958 when they described a patient with argininosuccinic aciduria. Since that time, patients with abnormalities of each of the enzymes involved in urea biosynthesis have been recognized. Studies from the Yale CRC described newborn males with hyperammonemia due to a defect of orithine transcarbamylase (26) , demonstrating that lethal forms of these defects could occur in the neontal period. The same investigators also elucidated an X-linked inheritance in ornithine transcarbamylase (201). Subsequent studies from the Stanford CRC demonstrated that carriers of ornithine transcarbamylase deficiency could be identified readily by the presence of elevated concentrations of urinary orotic acid after ingestion of a protein load (83).
Batshaw ct 01. (15) from the Johns Hopkins Pediatric CRC noted that defects of urea biosynthesis are not rare, and may be encountered as frequently as 1 in 2500 live births. Initially, they treated these infants and children with nitrogen-free ketoanalogues of essential amino acids because these patients had a great deal of difficulty with repeated episodes of hyperammonemia. The mortality rate in these patients was still extremely high. Recently, these investigators evolved a new approach to therapy for these patients (24) . An increased intake of arginine (except in patients with arginase deficiency) and sodium benzoate enhances the excretion of hippuric acid and lessens the risk of hyperammonemia in these patients. In addition, phenylacetic acid has also been used because this substance acetylates glutamine to form phenylacetyl glutamate, which is also readily excreted in urine. This treatment offers a promising therapeutic approach for infants, who heretofore had rapidly fatal courses.
Purine mctubolism abnormalities. CRC studies also characterized several inborn errors of purine and uric acid metabolism. The purines adenine and guanine form two of the four basic nucleotide units of DNA and RNA, respectively. Derived either from the diet or synthesized from smaller molecules, they are metabolized to xanthine and excreted as uric acid. ~xcessive accumulation of uric acid leads to hyperuricemia with or without gout. There is an alternative pathway for formation of purine nucleotides from preformed purines, and this pathway has been considered, until recently, to be merely a salvage mechanism. In 1964, Lesch and Nyhan (1 14) studied two brothers in the Johns Hopkins CRC who had mental retardation, choreoathetosis, and self mutilation in association with high blood uric acid levels and increased uric acid excretion. These cases, the first of several heritable disorders of purine metabolism now characterized, subsequently were shown to have a deficiency of the enzyme HPRT. Most of the patients with phenotypic Lesch-Nyhan disease have near absence of HPRT activity. Over 150 cases have been documented; the pedigrees of all patients have shown an X-linked inheritance pattern (79, 114).
More recent studies have documented the existence of patients with less severe HPRT deficiency and corresponding attenuation of their clinical expression (10, 223) . Description of the LeschNyhan syndrome has led to extensive research clarifying the importance of the purine nucleotide cycle in various tissues, including brain, and led to the characterization of a number of inborn defects of uric acid metabolism with mental retardation. Although these disorders are not presently treated effectively, it is now possible to provide genetic counseling and intrauterine diagnosis.
Amino acidurias. Studies in several CRCs have contributed to the understanding of inherited defects of amino acid metabolism, which often lead to early metabolic abnormalities and brain damage. Organic acidurias which result in profound acidosis and early death were included in these studies. Rosenberg et 01. Phenylketonuria is a well-known disorder of amino acid metabolism for which newborn screening has been legislated throughout the United States and other parts of the world. Early diagnosis and institution of a low phenylalanine diet ameliorates the brain damage in phenylketonuria. It has long been observed that a few children develop neurologic damage in spite of adequate dietary control of blood phenylalanine levels, but the explanation has not been apparent.
In the first major advance in this important area in some 15 yr, Kaufman et ul. (94,95) studyingpatients with dietary resistant phenylketonuria, described two variants of the disease. In both variants, phenylalanine hydroxylase (the usually deficient enzyme) levels were normal; however, in one variant, there was a profound deficiency of dihydropteridine reductase and in the other, there was a defect of tetrahydrobiopterin. Both substances are necessary for normal phenylalanine hydroxylase cofactor activity, and deficiency of either factor produces metabolic defects not correlated by normalizing blood phenylalanine levels. Appropriate therapy for the variant cases now is under investigation.
Curhohydrute metuholi.rm. Several important advances in carbohydrate metabolism have occurred in CRCs. One of these was the demonstration that careful control of diabetes mellitus in pregnant women during the last trimester of pregnancy minimizes the large variations in maternal blood sugar concentrations (80, 13 1, 189). Development of devices to frequently measure blood sugar and adjust insulin infusion rates to maintain near normal blood glucose levels throughout the day has led to the concept that careful control of maternal diabetes decreases the complications in the neonate. Improved monitoring of women during pregnancy has identified women at risk, and led to early and appropriate dietary and insulin treatment. Allowing these mothers to proceed to term has resulted in improved newborn survival. Techniques to evaluate these babies in lilero and recognize early complications have also been developed on CRCs (149, 150, 2 1 1, 220) .
The maturity of the blood sugar control mechanisms of small premature infants has been studied in a CRC. Dweck and colleagues (57) documented glucose intolerance in very low birth weight infants by demonstrating a high incidence of hyperglycemia with glucose loading and a reduced capacity to dispose of glucose (57) . The vulnerability of preterm infants to hyperglycemia and the need to monitor glucose closely in the early neonatal period was established.
Infantile hypoglycemia has been studied on CRCs. Pagliara and colleagues (1 59) reported the hypoalaninemia was a consistent correlate of ketotic hypoglycemia. This observation has been interpreted to indicate a limitation of available substrate for glucose production by the liver during fasting. An understanding of ketotic hypoglycemia, the most common of the noninsulininduced childhood hypoglycemias, has led to improved management.
CRCs research has characterized inborn defects of liver gluconeogenesis in infants with severe congenital hypoglycemia. Baker and Winegrad (1 2) and Pagliara and co-workers (1 60) reported two cases of severe acidosis and hypoglycemia due to a deficiency of hepatic fructose 1,6-diphosphatase, one of the rate limiting enzymes in liver gluconeogenesis.
The mechansim of the most frequent type of insulin-induced hypoglycemia has been characterized in several neonates. Hyperinsulinism has been documented and successful partial pancreatectomy has been performed. Yakovac and colleagues (239) reported that pathologic studies of the pancreas showed a congenital abnormality in the insulin producing beta-cells in nine of 12 of these infants and children. This was the first description of nesidioblastosis, characterized by an abnormal distribution of beta-cells outside their usual site in the islets of Langerhans in the pancreas. These cells secrete abnormal amounts of insulin, apparently uninfluenced by the normal control mechanisms, ( (165, 166) . (102, 163, 164, 192 ( i 7 , 36, 37, 84, 85, 87, 98, 103, 113, 178, 193) .
When a diet low in phenylalanine, tyrosine, and methionine was instituted, these abnormalities improved, including an increase in red cell glutathione levels. Glutathione participates in the conjugation o f foreign toxins and endogenous byproducts. Accordingly, a clinical trial at a Pediatric CRC was designed to increase glutathione levels in the liver. N-acetylcysteine has been successfully used in acetominophen toxicity because it prevents covalent bonding o f acetominophen byproducts to hepatic microsomes (177). hr-acetylcysteine is better than glutathione because it penetrates liver cells. Such treatment may inhibit the hepatic degeneration and malignant complications o f this disorder. Serial hepatic ultrasonograms in one patient disclosed a hepatoma detected before the development o f clinical findings. The patient then received a successful liver transplant. She is the only living patient with tyrosinemia with a viable liver transplant, cured o f the hepatic enzyme deficiency, and has no evidence o f metastases.
ENDOCRINE DISORDERS
Introdzlction. Clinical and laboratory studies conducted at Pediatric CRCs have greatly contributed to the understanding o f the physiologic development o f the adrenal gland, as well as to the pathogenesis and genetics o f disorders o f adrenal function
102, 16 1-166, 174, 175, 192). The adrenal gland produces two essential life-supporting hormones (mineralocorticoids and glucocorticoids); thus, advances in the knowledge o f the development o f the adrenal gland during perinatal life and deficiencies o f these hormones have made it possible to develop diagnostic tests for genetic disorders o f the adrenal gland applicable in the fetus and newborn. Congenital adrenal hyperplasia. CAH is a group o f inherited disorders o f adrenal steroidogenesis. Each disorder results from a deficiency o f one or more enzymes necessary for normal steroid synthesis. The most common form o f adrenal hyperplasia is caused by a deficiency o f 2 l -hydroxylase. In this disorder mineralocorticoid and glucocorticoid hormone synthesis are decreased, whereas male sex hormone synthesis is increased. In the salt-wasting form o f 21-hydroxylase deficiency, both male and female newborns are subject to early life-threatening salt-wasting crises, due to a severe deficiency o f aldosterone. Virilization o f external genitalia in female newborns may lead to incorrect sex assignment. This disorder is very common in the native Alaskan Eskimo, and is also relatively common in the general Caucasian population with an incidence o f 1 in 5000-
Therapeutic monitoring o f C A N . Endocrine research conducted at CRCs has contributed to the understanding o f the development and maturation o f adrenal and gonadal sex steroids from newborn to adult life
In 1977 the first report o f linkage between the major histocompatibility locus and 2 1-hydroxylase deficiency was reported (56) Statistical analysis of the linkage between CAH and HLA-B gave a peak Lod score of 9.5, indicating close genetic linkage (1 18, 240). As a result of this linkage, the CAH genotype of families of patients with CAH could be predicted by HLA genotvping. A family member sharing one HLA haplotype with the affected patient would be a heterozygote camer for 2 1-hydroxylase deficiency whereas a family member sharing n o haplotype with the patient would be unaffected. Extensive family studies confirmed this prediction. The 17-OH progesterone response to ACTH in family members predicted by HLA genotyping to be heterozygote carriers of the gene for 2 1-hydroxylase deficiency, was significantly higher than that of the general population or family members predicted by HLA genotyping to be unaffected. Heterozygote family members have a mild 2 1 -hydroxylase deficiency which can be unmasked by ACTH stimulation (120, 121) .
Cry'~.'/I'c und lute-onset 21-hydroxyluse deficiency.
In the course of these studies, a previously unrecognized form of 21-hydroxylase deficiency was discovered, cryptic 21-hydroxylase deficiency. Family members with this disorder have elevated baseline 17-OH progesterone concentrations, which rise with ACTH stimulation to levels significantly higher than those of the heterozygote family members. Similarly, serum A4-androstenedione is elevated in the baseline and the ACTH-stimulated state. Despite the deficiency of 21-hydroxylase activity, these family members are asymptomatic; they are of normal stature, have undergone normal puberty, and have normal fertility. These family members appear to be genetic hybrids, having one gene for the severe deficiency, inherited also by the index case with CAH, and one gene for the mild cryptic 2 1 -hydroxylase deficiency. Cryptic 2 1 -hydroxylase deficiency has also been demonstrated to be HLAlinked (1 16, 1 17) .
CRC studies of families of patients presenting with "late-onset" adrenal hyperplasia have demonstrated that this 2 1-hydroxylase deficiency is also transmitted by an autosomal recessive gene linked to HLA. The hormonal abnormalities of late-onset adrenal hyperplasia are similar to those of cryptic 21-hydroxylase deficiency, suggesting a similar degree of enzymatic deficiency. Further, both cryptic and late-onset adrenal hyperplasia are in genetic disequilibrium with the haplotype segment B14, C4A2, C4B2, Bfs, C2C, D R I ; however, patients with late-onset 21-hydroxylase deficiency present with variable signs of androgen excess, including early development of pubic hair, hirsutism, acne, and menstrual irregularities. HLA studies indicate that patients with "late-onset" adrenal hyperplasia may, like patients with cryptic 21-hydroxylase deficiency, have both the severe deficiency gene and the mild deficiency gene (99, 173).
As a result of these studies, nomograms were developed relating baseline and ACTH stimulated serum hormone concentrations in several groups including I) patients with CAH, cryptic, and late-onset adrenal hyperplasia; 2) family members predicted by HLA genotyping to be heterozygotes for these disorders; 3) members of the general population; and 4) family members predicted by HLA genotyping to be unaffected by the gene for 2 I-hydroxylase deficiency. These nomograms provide a means to diagnose 21-hydroxylase deficiency in the general population as well as in families with an affected member (140) (141) (142) (143) .
These studies suggest that CAH, cryptic, and late-onset adrenal hyperplasia are due to allelic variants at the locus for steroid 21-hydroxylase. Cryptic and late-onset adrenal hyperplasia are closely related and may be due to the same allelic variant at the steroid 2 1 -hydroxylase locus (1 16, 1 17, 153) .
PERINATAL NEUROLOGY
Inrrodllcfion. Along with the decreased infant mortality rate that occurred in the last 20 yr there was a n associated decrease in central nervous system morbidity in surviving children. Hospital-based studies in the United States reported rates beween 10-40%, with most values falling at the low end of the range (2, 44, 6 1, 157, 167, 184, 188, 21 6) . Clearly, this is less than the 50-75% morbidity reported in the literature of the late 1950s (52, 122, 123) .
The only available population-bused studies of the changing incidence of cerebral palsy are those from Sweden for the period 1954-1974 (74) . This report shows a decrease not only in the incidence of perinatal and neonatal mortality, but also in the overall incidence of cerebral palsy. The reduction was principally due to a drop in the incidence of spastic diplegia, especially in low birth weight infants. There was no reduction in spastic quadriplegia, the type of cerebral palsy most prevalent in asphyxiated full-term infants. As noted, data from hospitals in the USA over the past 20 yr reveal a reduced incidence of neurologic sequelae in infants (2500 g birth weight, and based on the Swedish data, a probable similar reduction among full-term infants.
Retrolen/ul fihroplu.sia. Oxygen has been recognized as the major factor causing retrolental fibroplasia in very LBW infants; however, other factors also contribute to or potentiate the vasoobliterative effect of oxygen on the immature retina. Shahinian and Malackowski (200) reported that retrolental fibroplasia increases with decreasing gestational age, but its severity is not related to birth weight or gestational age. A comparison of preterm infants with and without retrolental fibroplasia revealed that arterial blood gas values were similar in the first week of life for both groups; however, during subsequent weeks, infants who developed severe retrolental fibroplasia had significantly more time when their capillary oxygen tension was at undesirable values (P,,,O, > 50 m m Hg) than in the mild retrolental fibroplasia or control infants. They suggest that infants are at greatest risk from oxygen given late in the perinatal period. Current CRC studies suggest that vitamin E may prevent or decrease the severity of retrolental fibroplasia if given early in the course of oxygen administration (78).
Metabolic ,/uctor.r. uffecting bruin homeostusis. Several metabolic and physiologic abnormalities can be associated with significant central nervous system dysfunctionJdamage. These include asphyxia with impaired regulation of cerebral blood flow and/or shock, intracranial hemorrhage, hyponatremia, hypoglycemia, hyperbilirubinemia and sodium, calcium and magnesium electrolyte imbalance.
Dweck ef 01. (57) studied the effect of previous glucose exposure on glucose tolerance tests in preterm infants. Glucose exposure before the glucose tolerance tests resulted in higher mean plasma glucose, more frequent preinfusion hyperglycemia (glucose > 125 mgjdl), and a greater proportion of slow glucose disappearance rates when compared with the fasted infant. The data indicate a diminished tolerance to glucose in low birth weight infants, the vulnerability of preterm infants to hyperglycemia, and the need to carefully monitor glucose in the early neonatal period.
Perlstein ct ul. (1 7 1) studied the adaptation of 19 healthy fullterm infants to cold during the first 3 d of life. They demonstrated that newborns who were exposed to short periods of cold during the first 2 d of life have an enhanced ability to maintain their core body temperature when subsequently challenged by a heatlosing environment. Because thermal stability is one of the physiologic parameters associated with improved neurologic outcome, prevention of thermal stress is re-emphasized.
Neurologic dovelopmcnt. Amiel-Tison (4) described the neurologic evaluation of th newborn infant based on a n evaluation of passive and active tone, and primary reflexes. They showed how gestational age can be assessed at birth from the neurologic examination, thus distinguishing between preterm low birth weight infants and full-term infants of similar birth weight. With the development of this important evaluation tool, an increased interest in the neonatal neurologic examination was stimulated.
The follow-up evaluation of patients surviving specialized The neurologic abnormalities in surviving children usually consist of spasticity, hearing loss, vision loss, and seizure disorder. Mental retardation also occurred with and without motor deficits. Four children were handicapped but had normal IQs.
Eighteen of the study group with 1Q < 85 had some form of learning or behavior disorder. Several other studies from the 1960s confirm these findings.
Driscoll et al. (53) reported on the outcome of 54 infants born in 1977 and 1978 with birth weights of 1000 g or less. The incidence of neurologic deficits was 17% and the incidence of intellectual deficits was 13%. The major perinatal factor leading to neonatal mortality and subsequent morbidity was birth asphyxia. Twenty-six percent of the surviving infants had retrolental fibroplasia, but it usually was not severe. Sepsis was a significant factor in neonatal mortality in 10 of 28 infants. The authors comment that "although our incidence of disabling neurologic disorders is lower than in earlier reports for this weight group, the total longitudinal complication rate including intellectual impairment is still 30%." These authors believe that further improvement in intellectual outcome awaits prevention of perinatal asphyxia.
Zarin-Ackerman et al. (243) studied language development in two groups of 2-yr-old infants matched for social class but differing in birth conditions. One high risk group consisted of infants who suffered from birth asphyxia, hypercalcemia, and hyperglycemia whereas the other group contained normal infants. The high risk group had poorer language performance but little difference in perceptual cognitive development. These children will be followed for evaluation of abstract reasoning, memory and language.
Nezlropatholog,~. Brand et al. (21) in 1972, described the neuropathologic lesions of infants wiht RDS who survived from 12 h to 10 mo. The principal lesions in the central nervous system were fibrillary gliosis and increased vasculanzation, largely of the white matter. More severe lesions were present in the older patients. Lesions in gray matter were less significant. They included severe neuronal damage of the dorsal motor vagal nuclei, cerebellar Purkinje cell layer, or various auditory-cochlear nuclei. There was a 46% incidence of subependymal germinal matrix hemorrhage/intraventricular hemorrhage. Those with intracranial bleeding either died in the perinatal period or lived without any evidence of significant residual histologic effects. This paper is particularly important because it showed that lesions of preterm babies were primarily in the central portion of the brain rather than the cortical mantles.
Nezirophysiologicd studies. Several studies of the fetal EEG suggest that it can be recorded successfully in utero and does not change abruptly at birth (30, (33) (34) (35) . A computer program is useful for fetal EEG analysis, avoiding problems of visual interpretation. Mixed activity is dominant in the fetal EEGs of normal infants. Low voltage irregular activity occurs significantly more frequently in fetal EEGs of infants later found to be neurologically abnormal at 1 yr. Increased low voltage irregular activity in the fetal EEG appears to be associated with lower Apgar scores. Fetal EEG patterns, through discriminant function analysis, may be useful in predicting neurologic outcome at 1 yr of age.
These data provide some ability to identify the infant, at the earliest possible time after birth, whose central nervous system is altered sufficiently to cause permanent damage. One major difficulty is the inability to determine the length, severity, and acuteness of onset of an episode of intrauterine asphyxia. If the fetal EEG (because it does not change abruptly at birth) can be used immediately after birth, a neurologically injured infant may be identified early and immediate therapy instituted in an attempt to reduce permanent damage.
PERINATAL IMMUNOLOGY
Treatment qf immunodeficiency. Infants with severe defects of the immune system, particularly the T lymphocyte system, usually become ill in the first months of life and often are referred to medical centers with CRCs who have specialized staff and facilities to diagnose and care for such infants. One such child, David, a child with severe combined immunodeficiency, has been kept in a germ-free environment ("bubble") to prevent infection. Physicians at the CRC at Houston have devised a portable chamber so that he can go home inside his germ-free environment (236) . Although considerable insight into the disease and toward maintaining a germ-free environment vvas gleaned from this experience, this is not a practical means of caring for such infants.
At other centers the emphasis has been on restoration of immunity by transplantation of immunologically active tissue. This is a highly successful procedure when a histocompatible sibling is available as a donor; indeed, bone marrow transplantation, here and abroad, have successfully reconstituted 100 or more of such infants, allowing them to live a near normal life free of infection (1 15). Most infants in the USA have been cared for in CRCs.
When such a donor is unavailable, alternative strategies have been employed. Cooper et al. (39) suggested that defects in stem cells were responsible for severe combined immunodeficienc)~ in some instances, and demonstrated that fetal liver, the earliest lymphoid organ, could be used to provide stem cells devoid of graft-versus-host reactivity. Buckley and associates (25) at the Duke CRC performed a fetal liver transplant in a girl with severe combined immunodeficiency that has survived 6 yr. Although graft rejection is not a problem, graft-versus-host disease can be formidable, necessitating fetal liver from a donor less than 12 wk of gestation. Perhaps 10-15% of severe combined immunodeficiency patients transplanted with fetal livers are long-term survivors.
Fetal thymus transplants have been used successfully in children with pure T cell deficiency, especially in patients with thymic aplasia (DiGeorge syndrome) (8) . Thymic hormone therapy has also been utilized with some success (23 1).
Bone marrow transplantation in children with other imtnunodeficiencies have been accomplished. Parkman et ul. ( 168) at the CRC at Boston Children's Hospital have reported the correction of the hematologic and immunologic defects of the WiskottAldrich syndrome utilizing irradiation for marrow engraftment. Most recently, bone marrow transplantation of combined immunodeficiency has been achieved utilizing marrow from a parent who was mismatched at one-half of the HLA loci. The parental marrow was treated with a monoclonal antibody to remove those T cells which cause graft-versus-host disease (185). Alternatively, Kapoor el al. (93) have used soybean agglutinin and E rosetting techniques to remove mature T cells that cause GVH reactions. These therapies may permit widespread transplantation because a sibling donor is not necessary.
Adenosine deuminuse deficiency and immunodeficiency. A significant advance in the understanding of severe combined immunodeficiency was the discovery that one form of the disease. comprising about 10% of the total of patients with severe combined immunodeficiency, is associated with a deficiency of the enzyme ADA (132) . ADA is an enzyme which deaminates adenosine to inosine in the purine salvage pathway, and its deficiency was the first described biochemical defect resulting in immunodeficiency. Two other enzyme deficiencies have subsequently been associated with immunodeficiency: NP, an enzyme which converts inosine to hypoxanthine in the purine salvage pathway, and 5'-nucleotidase, an enzyme which converts man-ophosphorylated nucleosides to nucleosides and phosphate. NP deficiency has been associated with severe T lymphocyte deficiency (I 98) whereas nucleotidase deficiency has been associated with several B lymphocyte antibody deficiencies (59) .
Meuwissen and associates (132) , at the Albany, NY CRC summarized their findings in 13 patients with SCID and ADA deficiency. The defect, transmitted as an autosomal recessive trait, is often associated with radiographic abnormalities of the skeleton, and leads to thymic involution after birth. Erythrocytes are a convenient tissue for assay of ADA activity. In fact, a few drops of blood collected on filter paper were sufficient for screening newborns suspected of the disease.
One possible mechanism of action of ADA deficiency is the metabolic build up of deoxyadenosine. Mitchell and associates (133) showed that this metabolite is greatly elevated in the triphosphorylated form in ADA deficiency and is extremely toxic to T lymphoblastoid cell lines, but not to B cell lines. Deoxyguanosine also displayed this selective toxic effect. It is known that deoxyadenosine triphosphate is a potent inhibitor of ribonucleotide reductase, an enzyme that converts cytidine diphosphate to the deoxy form which is phosphorylated and, ultimately, incorporated into DNA. Although the profound T cell inhibition may be explained by this theory the B cell dysfunction in ADA deficiency cannot be explained. It is possible that loss of helper T cells, which cooperate with B cells for antibody production, is defective. An alternate explanation is that deoxyadenosine inhibits S-adenosylhomocysteine hydrolase and allows the buildup of S-adenosylhomocysteine, which in turn inhibits important methylation pathways.
In addition to the complete absence of key enzymes producing a state of immunodeficiency, Fox et ul. (62) at the Michigan CRC discovered a partial NP deficiency with immunodeficiency, involving a mutant NP enzyme. The mutant enzyme differed from the normal NP enzyme by a 10-fold greater binding constant for substrate, by being more susceptible to thermal inactivation, and by bearing more cationic groups. It is likely that the altered properties of the mutant enzyme account for the mild immunodeficiency.
Enzyme replacement therapy in SCID-ADA deficient patients has been attempted utilizing normal erythrocytes, rich in ADA. Polmar and associates (1 76) at the Case Western Reserve CRC reversed the lymphocyte defects in a patient with ADA deficiency by giving repeated red cell transfusions. Initial enthusiasm for this mode of therapy was tempered by the report of Schmalstieg et a/. (199) at the University of Texas, Galveston CRC who noted only a partial response to red cell and plasma transfusions. This therapy does not permanently correct the enzyme deficiency, and biochemical and immunologic relapse occurs when the erythrocyte transfusions are stopped. Nevertheless, these studies suggest the possibility of immunoreconstitution when more suitable forms of enzyme replacement become available.
Another association of enzyme deficiency with immunodeficiency was reported by Cowan et a/. (40) at the University of California, San Francisco CRC who reported three siblings with impaired T and B cell responses in biotin-dependent carboxylase deficiency. These children presented with neurologic abnormalities, intermittent lactic acidosis, and raised urinary levels of /Ihydroxypropionate, methylcitrate, /I-methylcrotonylglycine, and /I-hydroxyisovaleric acid which were responsive to biotin therapy.
Intravenous ~mmunoglohulin replacement therapy. In antibody deficiency disorders it is desirable to maintain IgG levels as close as possible to the normal level. Such therapy minimizes infectious complications and improves the likelihood of prolonged symptom-free survival. Beginning in the 1950s the gammaglobulin (Cohn 11) fraction of serum, obtained by alcohol and low temperature fractionation, was used to treat hypogammaglobulinemic individuals. This gammaglobulin preparation forms aggregates which, if given intravenously, activates the complement and kinin systems and produces severe anaphylactic reactions (and death in a few instances). Generally, gammaglobulin (0.7 ml/kg of body weight) is given by intramuscular injection once per month (i.e., 50 ml in a 70 kg subject). This dose raises the serum concentration by 100-200 mg/dl and greatly reduces the morbidity of infections. Local complications of intramuscular gammaglobulin include sterile abscesses, tenderness, fibrosis, and sciatic nerve injury. Intramuscular injections are particularly difficult to administer to malnourished infants with immunodeficiency because of poor muscle mass.
It was thus desirable to develop a safe and effective immunoglobulin for intravenous use. Nolte ct a/. (144) at the Oregon CRC administered intravenously a modified IgG that was reduced and alkylated to 20 hypogammaglobulinemic patients. The mean immediate serum concentration rise was 248 mg/dl compared to a mean 90 mg/dl rise after intramuscular injections. More importantly, the acute infection rate in the intravenous group was 30% of that in the intramuscular group (P < 0.05).
Mild but bothersome side effects of the intravenous IgG occurred in 50% of patients and included nausea, tlushing, fever, muscle cramps, and headache.
A 1980 follow-up study from the Oregon, Duke, and the University of Washington CRCs compared the intravenous use of reduced and alkylated IgG alone or in the presence of a 10 mg/dl solution of maltose stabilizer (148) . They noted a remarkable reduction in side effects with the IgG-maltose infusion (3 of 29 patients versus 22 of 29, P < 0.001). They concluded that the IgG-maltose preparation was a safe and efficient agent for use in IgG immunodeficiency diseases.
Ammann and associates (5) 
Viral inJections o f t h e newborn.
It is estimated that 6-8% of all live births are complicated by viral infections as contrasted to 1-2% by bacterial infections (Table 1) (1 58). Viral infections of the newborn can be acquired before, at, or immediately after birth. Major sequelae of these infections include abortion, stillbirth, congenital malformation, prematurity, intrauterine growth retardation, spastic movement disorders, acute disease at birth, persistent postnatal infections, mental retardation and attention deficit disorders. Systemic viral illness in the mother can reach the fetus by replication through the placenta, or by transplacental passage of infected maternal lymphocytes. Postnatally, passage of the newborn through an infected birth canal and ingestion of 
The Effect of Small but Sustained Elevations in
Summary
Although growth hormone (GH) concentrations are not always pathologically elevated in patients with acromegaly, it has been suggested that the metabolic and somatic consequences of this condition may be due to a loss of the normal episodic secretion of G H . To examine the effects of maintaining modest but constant levels of circulating C H , we administered continuous subcutaneous infusions of growth hormone (CSIGEI) to eight previously untreated GH-deficient children (6-19 yr) .
CSlGH given for 90 h in doses equivalent to the standard dose for replacement therapy, raised mean serum GH levels from less than 3.0 to 5.9 + 1.0 ng/ml. In comparison, 24-h mean GH levels in five normal adolescents averaged 10.1 + 1.5 ng/ml. As expected, however, normals showed much more variability in G H concentration. The constant elevations in serum G H levels achieved with CSIGH produced significant impairment of oral glucose tolerance. During CSIGH, plasma glucose concentrations 60-1 20 min after oral glucose loading were 30-40 mg/dl higher than corresponding pre-infusion values (P < 0.01). This impairment of oral glucose tolerance during CSIGH occurred despite a doubling of the area under the insulin/time curve after oral glucose (P < 0.02 versus pre-infusion area). Indeed, plasma insulin lebels after oral glucose in patients on CSlGH exceeded those observed in normal controls, suggesting that CSIGH had induced a degree of insulin resistance.
There was a transient increase in plasma free fatty acid levels on the first day of CSIGH. Somatomedin-C concentration remained unchanged in four of six patients. We conclude that small but sustained increases in growth hormone concentrations in G H deficiency can, when infused continuously, have effects on fuel metabolism similar to those observed during pathologic G H hypersecretion.
Abbreviations CSIGH, continuous subcutaneous infusions of growth hormone FFA, free fatty acids C H , growth hormone GH-secreting pituitary adenomas are characterized clinically by excessive somatic growth and hyperinsulinemia with or without glucose intolerance. In a recent study of patients with such adenomas, however. Clemmons ' I a/. (3) demonstrated that the manifestations of acromegaly were not closely dependent on serum GH levels. Indeed, in certain individuals increased heel pad thickness and hyperglycemia were observed despite basal GH levels that lay within the normal range.
